Search research articles
Contact Us
Filters
Showing results (1-10 of 6) with videos related to
Page
of 1
Sort By:
JAAD Case Reports
|
April 20, 2026
Nonresponse of basal cell carcinomas to immune checkpoint inhibition therapy for melanoma: A case series
Elizabeth F Sher, Ata S Moshiri, Ian W Tattersall
Seminars in Perinatology
|
March 15, 2025
Melanoma in pregnancy
Christina S Oh, Elizabeth F Sher, Amy K Bieber
Clinical and Experimental Dermatology
|
February 12, 2025
Dermoscopic Features of Ethnic Acral Melanosis in Fitzpatrick Skin Types IV-VI
Elijah Rodriguez, Elizabeth F Sher, Michelle Juarez, et al.
Biorxiv : the Preprint Server for Biology
|
September 26, 2025
Targeting DNA Polymerase Epsilon Leads to Tumor Clearance and Activation of an NF-κB-mediated inflammatory response in Triple Negative Breast Cancer
Elizabeth F Sher, Kenji M Fujihara, Anthony Tao, et al.
JAAD International
|
November 19, 2025
Tralokinumab for moderate-to-severe atopic dermatitis: A viable option for dupilumab nonresponders
Christine T Olagun-Samuel, Christine C Akoh, Nnaemeka Anyanwu, et al.
Cancer Research
|
April 21, 2026
Targeting DNA Polymerase Epsilon Induces Tumor Clearance and Activates an NF-κB-Mediated Inflammatory Response in Triple Negative Breast Cancer
Elizabeth F Sher, Kenji M Fujihara, Anthony Tao, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 6) with videos related to
Sort By:
Page
of 1
JAAD Case Reports
|
April 20, 2026
Nonresponse of basal cell carcinomas to immune checkpoint inhibition therapy for melanoma: A case series
Elizabeth F Sher, Ata S Moshiri, Ian W Tattersall
Seminars in Perinatology
|
March 15, 2025
Melanoma in pregnancy
Christina S Oh, Elizabeth F Sher, Amy K Bieber
Clinical and Experimental Dermatology
|
February 12, 2025
Dermoscopic Features of Ethnic Acral Melanosis in Fitzpatrick Skin Types IV-VI
Elijah Rodriguez, Elizabeth F Sher, Michelle Juarez, et al.
Biorxiv : the Preprint Server for Biology
|
September 26, 2025
Targeting DNA Polymerase Epsilon Leads to Tumor Clearance and Activation of an NF-κB-mediated inflammatory response in Triple Negative Breast Cancer
Elizabeth F Sher, Kenji M Fujihara, Anthony Tao, et al.
JAAD International
|
November 19, 2025
Tralokinumab for moderate-to-severe atopic dermatitis: A viable option for dupilumab nonresponders
Christine T Olagun-Samuel, Christine C Akoh, Nnaemeka Anyanwu, et al.
Cancer Research
|
April 21, 2026
Targeting DNA Polymerase Epsilon Induces Tumor Clearance and Activates an NF-κB-Mediated Inflammatory Response in Triple Negative Breast Cancer
Elizabeth F Sher, Kenji M Fujihara, Anthony Tao, et al.
Page
of 1